RETRACTED: Cytochrome P450 3A5 polymorphism affects the metabolism of sorafenib and its toxicity for hepatocellular carcinoma cells <i>in vitro</i>

Hong-yan Song, Jing-sheng Xia, Yong-gang Chen, Ling Chen

Open source

DOI
10.1177/09603271211052989
Published
2021-11-16
Container
Human &amp; Experimental Toxicology
Publisher
SAGE Publications
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/09603271211052989,
  title = {RETRACTED: Cytochrome P450 3A5 polymorphism affects the metabolism of sorafenib and its toxicity for hepatocellular carcinoma cells
                    <i>in vitro</i>},
  author = {Hong-yan Song and Jing-sheng Xia and Yong-gang Chen and Ling Chen},
  year = {2021},
  journal = {Human \&amp; Experimental Toxicology},
  doi = {10.1177/09603271211052989},
  url = {https://doi.org/10.1177/09603271211052989}
}

RIS

TY  - JOUR
TI  - RETRACTED: Cytochrome P450 3A5 polymorphism affects the metabolism of sorafenib and its toxicity for hepatocellular carcinoma cells
                    <i>in vitro</i>
AU  - Hong-yan Song
AU  - Jing-sheng Xia
AU  - Yong-gang Chen
AU  - Ling Chen
PY  - 2021
JO  - Human &amp; Experimental Toxicology
DO  - 10.1177/09603271211052989
UR  - https://doi.org/10.1177/09603271211052989
ER  - 

APA

Song, H., Xia, J., Chen, Y., & Chen, L. (2021). RETRACTED: Cytochrome P450 3A5 polymorphism affects the metabolism of sorafenib and its toxicity for hepatocellular carcinoma cells <i>in vitro</i>. Human &amp; Experimental Toxicology. https://doi.org/10.1177/09603271211052989

Source records